Citius Pharmaceuticals, Inc.

CTXRNASDAQHealthcare● Active

$0.59

+$0.03(+5.21%)

Market Cap$6584015

P/E Ratio—

52W High$2.48

52W Low$0.476

Avg Volume809K

Open$0.57

Beta0.98

Insider Trades Ownership Employees

Citius Pharmaceuticals, Inc. (CTXR) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · CTXR · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Citius Pharmaceuticals, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

CTXR insider buying and selling by quarter

CTXR insider selling · CTXR insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

6.7M3.4M0

2021 Q3

2021 Q4

2022 Q4

2023 Q1

2023 Q4

2024 Q1

2024 Q2

2024 Q3

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Recent insider transactions

CTXR executive sell shares · CTXR board member insider trading · CTXR insider trading SEC filing

Showing 4 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Mar 13, 2024	Holuka Eugene Myron Director	Option	2,415	$0.01	$36	2,415	Form 4
Mar 13, 2024	Holuka Eugene Myron Director	Other	48	$0.75	$36	2,367	Form 4
Mar 4, 2024	Webb Carol Director	Option	12,071	$0.01	$181	12,071	Form 4
Mar 4, 2024	Webb Carol Director	Other	236	$0.77	$181	11,835	Form 4

Holuka Eugene Myron

Director

Option

Date

Mar 13

2,415

Price

$0.01

Value

$36

View Form 4 on SEC.gov

Holuka Eugene Myron

Director

Other

Date

Mar 13

Price

$0.75

Value

$36

View Form 4 on SEC.gov

Webb Carol

Director

Option

Date

Mar 4

12,071

Price

$0.01

Value

$181

View Form 4 on SEC.gov

Webb Carol

Director

Other

Date

Mar 4

236

Price

$0.77

Value

$181

View Form 4 on SEC.gov

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About CTXR insider trading

CTXR insider trades

Citius Pharmaceuticals, Inc. (CTXR) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including CTXR. Over the past 12 months, 0 insiders have filed transactions with the SEC. CTXR insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Citius Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

CTXR insider trading · 5 questions

The insiders of Citius Pharmaceuticals, Inc. (CTXR) include executives and directors such as CTXR, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

CTXR board member insider tradingwho are CTXR insidersCTXR insider rosterCitius Pharmaceuticals, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026